4//SEC Filing
Novack David F 4
Accession 0001628280-26-002640
CIK 0001029142other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:33 PM ET
Size
14.2 KB
Accession
0001628280-26-002640
Insider Transaction Report
Form 4
Novack David F
President & COO
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-15$6.80/sh+20,000$136,100→ 83,344 total - Exercise/Conversion
Common Stock
[F1]2026-01-15$10.47/sh+94,000$984,180→ 177,344 total - Sale
Common Stock
[F1][F2]2026-01-15$15.64/sh−114,000$1,782,960→ 63,344 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4][F3]2026-01-15−20,000→ 146,528 totalExercise: $6.80Exp: 2026-12-15→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4][F3]2026-01-15−85,655→ 0 totalExercise: $10.47Exp: 2026-02-21→ Common Stock (85,655 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4][F3]2026-01-15−8,345→ 0 totalExercise: $10.47Exp: 2026-02-21→ Common Stock (8,345 underlying)
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 6, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.585 to $15.665; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
- [F3]Fully vested.
- [F4]Not applicable.
Signature
David F. Novack, by /s/ Trevor Dutcher, Attorney-in-Fact|2026-01-20
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001573072
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:33 PM ET
- Size
- 14.2 KB